FDA Approves ruxolitinib cream for treatment of Atopic Dermatitis Dr Kartikeya Kohli22 Sept 2021 9:30 PM ISTThe US food and drug administration has approved a topical selective Janus kinase (JAK)1/JAK2 inhibitor ruxolitinib (Opzelura) for the treatment of...
FDA Authorizes Software that Can Help Identify Prostate Cancer Hina Zahid22 Sept 2021 9:30 AM ISTThe U.S. Food and Drug Administration authorized marketing of Paige Prostate AI-based software that will help pathologists with a supplementary...
FDA Clears First ever Technology to Distinguish between Bacterial and Viral Infections Dr Kartikeya Kohli21 Sept 2021 9:30 PM ISTHaifa, Israel, Boston, MA - The U.S. Food and Drug Administration (FDA) has granted 510(k)clearance to first technology to Distinguish between...
FDA Approves First Biosimilar for Treating Macular Degeneration and Other Eye Diseases Dr Kartikeya Kohli21 Sept 2021 11:00 AM ISTThe U.S. Food and Drug Administration has approved Byooviz (ranibizumab-nuna) as the first biosimilar to Lucentis (ranibizumab injection) for the...
FDA approves first targeted oral therapy for very rare lung cancer Dr Kartikeya Kohli17 Sept 2021 9:39 AM ISTCAMBRIDGE, Mass - The U.S. Food and Drug Administration (FDA) has approved EXKIVITY (mobocertinib) for the treatment of adult patients with...
Trifarotene- The latest retinoid for acne management Dr Manoj Kumar Nayak6 Sept 2021 9:00 AM ISTTrifarotene- The latest retinoid for acne management Retinoids, both topical and systemic are a crucial class of drugs for dermatologists. They...
FDA approves novel rehabilitation system for stroke victims Dr Kartikeya Kohli28 Aug 2021 9:15 AM ISTThe U.S. Food and Drug Administration has approved first-of-its-kind, drug-free rehabilitation system intended to treat moderate to severe upper...
FDA approves empagliflozin for heart failure with reduced ejection fraction in adults Dr. Kamal Kant Kohli21 Aug 2021 7:15 AM ISTThe U.S. Food and Drug Administration has approved Jardiance (empagliflozin) to reduce the risk of cardiovascular mortality plus hospitalization for...
FDA approves drug for chronic, excessive sleepiness during daytime Dr. Kamal Kant Kohli13 Aug 2021 8:15 AM ISTThe US Food and Drug Administration has approved a new indication for Xywav for idiopathic hypersomnia (IH) in adults. Xywav (calcium, magnesium,...
FDA approves new treatment for rare genetic disease- Pompe disease Dr. Kamal Kant Kohli6 Aug 2021 10:12 PM ISTThe U.S. Food and Drug Administration has approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and...
FDA expands approval to DALVANCE for Treatment of Acute Bacterial Skin Infections in kids Hina Zahid28 July 2021 3:15 PM ISTThe U.S. Food and Drug Administration (FDA) has approved DALVANCE (dalbavancin) for the treatment of acute bacterial skin and skin structure...
FDA approves Vitamin A as breakthrough therapy for Stargardt disease and AMD Dr. Nandita Mohan16 July 2021 10:15 AM ISTALK-001 is a chemically-modified vitamin A which has been granted a breakthrough by the Food and Drug Administration (FDA) for the prevention and...
